Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.

Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michael Nagler, Lucas M Bachmann, Pirmin Schmid, Pascale Raddatz Müller, Walter A Wuillemin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/20b94a5e984f4fc68374b4ddc155efe0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:20b94a5e984f4fc68374b4ddc155efe0
record_format dspace
spelling oai:doaj.org-article:20b94a5e984f4fc68374b4ddc155efe02021-11-18T08:22:26ZPatient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.1932-620310.1371/journal.pone.0095761https://doaj.org/article/20b94a5e984f4fc68374b4ddc155efe02014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24748062/?tool=EBIhttps://doaj.org/toc/1932-6203Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patients (5818.9 patient-years) were analysed and no patient were lost to follow-up. Median follow-up was 4.3 years (range 0.2-12.8 years). Median age at the time of training was 54.2 years (range 18.2-85.2) and 34.6% were women. All-cause mortality was 1.4 per 100 patient-years (95% CI 1.1-1.7) with a higher rate in patients with atrial fibrillation (2.5; 1.6-3.7; p<0.001), patients>50 years of age (2.0; 1.6-2.6; p<0.001), and men (1.6; 1.2-2.1; p = 0.036). The rate of thromboembolic events was 0.4 (0.2-0.6) and independent from indications, sex and age. Major bleeding were observed in 1.1 (0.9-1.5) per 100 patient-years. Efficacy was comparable to standard care and new oral anticoagulants in a network meta-analysis. PSM of properly trained patients is effective and safe in a long-term real-life setting and robust across clinical subgroups. Adoption in various clinical settings, including those with limited access to medical care or rural areas is warranted.Michael NaglerLucas M BachmannPirmin SchmidPascale Raddatz MüllerWalter A WuilleminPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e95761 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Michael Nagler
Lucas M Bachmann
Pirmin Schmid
Pascale Raddatz Müller
Walter A Wuillemin
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
description Patient self-management (PSM) of oral anticoagulation is under discussion, because evidence from real-life settings is missing. Using data from a nationwide, prospective cohort study in Switzerland, we assessed overall long-term efficacy and safety of PSM and examined subgroups. Data of 1140 patients (5818.9 patient-years) were analysed and no patient were lost to follow-up. Median follow-up was 4.3 years (range 0.2-12.8 years). Median age at the time of training was 54.2 years (range 18.2-85.2) and 34.6% were women. All-cause mortality was 1.4 per 100 patient-years (95% CI 1.1-1.7) with a higher rate in patients with atrial fibrillation (2.5; 1.6-3.7; p<0.001), patients>50 years of age (2.0; 1.6-2.6; p<0.001), and men (1.6; 1.2-2.1; p = 0.036). The rate of thromboembolic events was 0.4 (0.2-0.6) and independent from indications, sex and age. Major bleeding were observed in 1.1 (0.9-1.5) per 100 patient-years. Efficacy was comparable to standard care and new oral anticoagulants in a network meta-analysis. PSM of properly trained patients is effective and safe in a long-term real-life setting and robust across clinical subgroups. Adoption in various clinical settings, including those with limited access to medical care or rural areas is warranted.
format article
author Michael Nagler
Lucas M Bachmann
Pirmin Schmid
Pascale Raddatz Müller
Walter A Wuillemin
author_facet Michael Nagler
Lucas M Bachmann
Pirmin Schmid
Pascale Raddatz Müller
Walter A Wuillemin
author_sort Michael Nagler
title Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
title_short Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
title_full Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
title_fullStr Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
title_full_unstemmed Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
title_sort patient self-management of oral anticoagulation with vitamin k antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/20b94a5e984f4fc68374b4ddc155efe0
work_keys_str_mv AT michaelnagler patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy
AT lucasmbachmann patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy
AT pirminschmid patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy
AT pascaleraddatzmuller patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy
AT walterawuillemin patientselfmanagementoforalanticoagulationwithvitaminkantagonistsineverydaypracticeefficacyandsafetyinanationwidelongtermprospectivecohortstudy
_version_ 1718421847593189376